YOLFTbeta
30

Huaxia Eye Hospital Group Co. Ltd. A

301267 · SHE · Healthcare / Medical Care Facilities

14.53CNY-0.23 (-1.56%)

Price History

Full chart

Market Stats

Previous Close14.76
Open14.77
Day Range14.50 – 14.92
52-Week Range14.30 – 20.41
Volume5.28M
Market Cap12.73B
P/E (TTM)28.07
Forward P/E0.00
EPS0.54
Dividend Yield3.17%
Beta0.47
50-Day Avg15.65
200-Day Avg17.00

About

Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis, treatment, and other ophthalmic medical services for patients with eye disease and myopia; prevention and intervention work to the public. It offers services in the areas of cataract, refractive errors, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular surface, glaucoma, orbital and ocular tumors, optometry, and ocular trauma, as well as engages in community services. The company was founded in 1997 and is based in Xiamen, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Qingcan Su
  • Employees8.20K
  • HeadquartersNo. 999 Wutong West Road, Xiamen, China, 361006, China
  • Websitehttps://www.huaxiaeye.com

Leadership

  • Mr. Qingcan SuChairman of the Board & GM · b. 1969
  • Ms. Lu Yan ChenFinancial Director & Accounting Supervisor · b. 1978
  • Mr. Xiaofeng LiDeputy GM & Non-Independent Director · b. 1972
  • Mr. Nai En CaoBoard Secretary · b. 1975
  • Mr. Zhiyong ZhangDeputy General Manager · b. 1982
  • Mr. Bin Bin ZhangDeputy General Manager · b. 1964

Financials

Income Statement

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.51B3.06B3.23B4.01B4.03B4.14B
Growth (%)-+21.86%+5.51%+24.12%+0.35%+2.78%
Cost of Revenue1.45B1.65B1.68B2.05B2.25B2.35B
Gross Profit1.06B1.41B1.55B1.97B1.78B1.79B
Gross Margin42.16%46.04%48.05%49.03%44.19%43.31%
Operating Expense564.92M720.99M806.17M1.06B1.14B1.15B
Operating Income495.28M689.81M747.35M912.06M635.90M637.96M
Operating Margin19.70%22.51%23.11%22.73%15.79%15.41%
EBITDA--966.08M1.17B917.70M953.75M
EBITDA Margin--29.88%29.07%22.79%23.04%
Net Income334.46M454.92M513.82M665.93M428.64M440.65M
Net Income Margin13.30%14.85%15.89%16.59%10.64%10.65%
R&D19.79M25.20M49.27M69.68M70.63M61.44M
R&D as % of Total Revenue0.79%0.82%1.52%1.74%1.75%1.48%
Interest Expense6.22M37.61M38.36M38.04M45.13M46.96M
Interest Expense % of Total Revenue0.25%1.23%1.19%0.95%1.12%1.13%

Balance Sheet

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.77B3.22B6.74B7.38B7.92B7.56B
Total Liabilities1.31B1.37B1.61B1.66B1.90B2.10B
Total Equity1.42B1.83B5.12B5.66B5.79B5.27B
Cash503.41M953.42M1.35B3.92B3.49B2.52B

Cash Flow

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow590.62M798.02M769.98M961.24M820.30M867.58M
Capital Expenditure163.29M173.63M235.31M448.43M279.59M231.99M
Free Cash Flow427.34M624.38M534.68M512.81M540.71M635.59M
Dividends Paid6.57M158.32K503.09K157.32M92.11M260.98M
FCF to OCF72.35%78.24%69.44%53.35%65.92%73.26%
Dividend Paid to FCF1.54%0.03%0.09%30.68%17.04%41.06%

Earnings

Report DateApr 23, 2023Aug 29, 2023Oct 24, 2023Apr 25, 2024Aug 28, 2024Oct 29, 2024Apr 27, 2025Aug 25, 2025Oct 29, 2025Apr 29, 2026Aug 28, 2026
EPS Estimate-----------
EPS Actual0.270.240.240.130.130.190.010.160.180.210.14
Surprise-----------
TimingPre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-market----

Key Statistics & Ratios

Market Cap12.73B
Enterprise Value9.78B
Trailing P/E28.07
Forward P/E0.00
Price / Sales3.04
Price / Book2.34
EPS0.54
Book Value6.51
Revenue (TTM)4.19B
Gross Profit (TTM)1.78B
EBITDA766.24M
Profit Margin10.77%
Operating Margin15.21%
Return on Equity7.48%
Return on Assets4.72%
Shares Outstanding840.00M
Shares Float200.83M
Beta0.47
Dividend Yield3.17%
Dividend Rate0.48
Payout Ratio48.79%

Dividends

20261×
0.17Jul 3, 2026
20252×
0.09Dec 22, 20250.22Jul 14, 2025
20241×
0.11Jul 15, 2024
20231×
0.28Jul 11, 2023

Stock Splits

  • Jul 11, 20231.5:1